
Materialise Spon Ads Ea Repstg 1 Ord (MTLS) Stock
Belgian 3D printing software and medical planning services provider. Here's the price, business snapshot, and what's worth knowing about Materialise Spon Ads Ea Repstg 1 Ord in September 2026.
Materialise NV (MTLS) is a Belgium‑based provider of 3D printing software and additive manufacturing services. The company offers a mix of software licences, on‑demand manufacturing and certified medical planning and surgical guide solutions, serving healthcare, industrial and consumer markets. With a market capitalisation around $362.7m, MTLS sits in the small‑cap segment where growth potential can come with higher volatility. Key growth drivers include broader adoption of additive manufacturing, advances in medical device applications and recurring software revenues; challenges include competition, execution risk in scaling manufacturing operations and regulatory scrutiny in medical markets. Investors should be aware that revenues can be cyclical and that past performance does not guarantee future returns. This summary is for general educational purposes only and is not personalised financial advice — consider your own objectives and risk tolerance before making investment decisions.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying Materialise's stock, expecting it to rise significantly in value.
Financial Health
Materialise is performing well with solid revenue and cash flow, indicating strong operational strength.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Adoption Momentum
Wider uptake of 3D printing across industries could support revenue growth, though technology adoption may take time and results can vary.
Medical Applications
Strong presence in medical planning and devices provides differentiation, but medical products face regulatory and reimbursement challenges.
Software & Services
Software licences and on‑demand manufacturing give diversified revenue streams, although competition and execution risk remain important considerations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.